↓ Skip to main content

Clinical Evidence for the Microbiome in Inflammatory Diseases

Overview of attention for article published in Frontiers in immunology, April 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
25 X users
facebook
1 Facebook page

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
168 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical Evidence for the Microbiome in Inflammatory Diseases
Published in
Frontiers in immunology, April 2017
DOI 10.3389/fimmu.2017.00400
Pubmed ID
Authors

Ann E. Slingerland, Zaker Schwabkey, Diana H. Wiesnoski, Robert R. Jenq

Abstract

Clinical evidence is accumulating for a role of the microbiome in contributing to or modulating severity of inflammatory diseases. These studies can be organized by various organ systems involved, as well as type of study approach utilized, whether investigators compared the microbiome of cases versus controls, followed patients longitudinally, or intervened with antibiotics, prebiotics, or bacterial introduction. In this review, we summarize the clinical evidence supporting the microbiome as an important mechanism in the onset and maintenance of inflammation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 168 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 168 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 35 21%
Researcher 33 20%
Student > Bachelor 17 10%
Student > Ph. D. Student 13 8%
Student > Postgraduate 12 7%
Other 21 13%
Unknown 37 22%
Readers by discipline Count As %
Medicine and Dentistry 37 22%
Biochemistry, Genetics and Molecular Biology 20 12%
Agricultural and Biological Sciences 20 12%
Immunology and Microbiology 14 8%
Nursing and Health Professions 11 7%
Other 23 14%
Unknown 43 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2019.
All research outputs
#2,657,321
of 25,703,943 outputs
Outputs from Frontiers in immunology
#2,707
of 32,216 outputs
Outputs of similar age
#47,823
of 325,536 outputs
Outputs of similar age from Frontiers in immunology
#44
of 417 outputs
Altmetric has tracked 25,703,943 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,216 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,536 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 417 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.